Abstract
The obesity hypoventilation syndrome (OHS) characterized by persistent hypercapnia with obesity has many causes. Probably the most common cause is the obstructive sleep apnea syndrome and related conditions, but some cases may occur along with depressed chemosensitivity and few apneas during sleep. The mechanisms that produce waking hypercapnia are still uncertain. Treatment of OHS consists of weight management and sometimes requires treatment with continuous applied pressure or non invasive positive pressure ventilation.
Current Respiratory Medicine Reviews
Title: The Obesity Hypoventilation Syndrome
Volume: 4 Issue: 2
Author(s): Neil S. Cherniack
Affiliation:
Abstract: The obesity hypoventilation syndrome (OHS) characterized by persistent hypercapnia with obesity has many causes. Probably the most common cause is the obstructive sleep apnea syndrome and related conditions, but some cases may occur along with depressed chemosensitivity and few apneas during sleep. The mechanisms that produce waking hypercapnia are still uncertain. Treatment of OHS consists of weight management and sometimes requires treatment with continuous applied pressure or non invasive positive pressure ventilation.
Export Options
About this article
Cite this article as:
Cherniack S. Neil, The Obesity Hypoventilation Syndrome, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222740
DOI https://dx.doi.org/10.2174/157339808784222740 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation
Current Cardiology Reviews Regenerative Potential of Stem Cells Derived from Human Exfoliated Deciduous (SHED) Teeth during Engineering of Human Body Tissues
Current Stem Cell Research & Therapy Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy
Current Molecular Medicine NPY and Cardiac Diseases
Current Topics in Medicinal Chemistry Respiratory Syncytial Virus (RSV) Prevention and Treatment: Past, Present, and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry Anti-Tumor Necrosis Factor Blocking Agents in the Treatment of Systemic Vasculitis
Current Immunology Reviews (Discontinued) Recent Advances in the Design of Cathepsin S Inhibitors
Current Topics in Medicinal Chemistry Utility and Limitations of SP600125, an Inhibitor of Stress-Responsive c-Jun N-Terminal Kinase
Current Enzyme Inhibition Treatment of Heyde's Syndrome by Aortic Valve Replacement
Current Cardiology Reviews Thrombotic Microangiopathy and Occult Neoplasia
Cardiovascular & Hematological Disorders-Drug Targets Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Patent Selections
Recent Patents on Cardiovascular Drug Discovery Current Hydrogel Solutions for Repairing and Regeneration of Complex Tissues
Current Medicinal Chemistry Vitamin D3, D2 and Arterial Wall Properties in Coronary Artery Disease
Current Pharmaceutical Design Vascular Dementia: Atherosclerosis, Cognition and Alzheimers Disease
Current Alzheimer Research Beta-Blockers as First Line Treatment of Hypertension: A Proponents View
Current Hypertension Reviews Critical Roles of Insulin-Induced Senescence in Diabetic Vasculopathy
Vascular Disease Prevention (Discontinued) Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Current Pharmaceutical Design Calcium as a Molecular Target in Angiogenesis
Current Pharmaceutical Design Exercise and Cardiac Preconditioning Against Ischemia Reperfusion Injury
Current Cardiology Reviews